12-71677010-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_031435.4(THAP2):c.589A>G(p.Ser197Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_031435.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
THAP2 | ENST00000308086.3 | c.589A>G | p.Ser197Gly | missense_variant | 3/3 | 1 | NM_031435.4 | ENSP00000310796.2 | ||
ENSG00000258064 | ENST00000548802.1 | n.195+2612A>G | intron_variant | 3 | ENSP00000454911.2 | |||||
THAP2 | ENST00000551488.5 | c.*42A>G | downstream_gene_variant | 3 | ENSP00000448904.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 15, 2024 | The c.589A>G (p.S197G) alteration is located in exon 3 (coding exon 3) of the THAP2 gene. This alteration results from a A to G substitution at nucleotide position 589, causing the serine (S) at amino acid position 197 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.